Gene · 200424
Papers2,594
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,594
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Searching for molecular hypoxia sensors among oxygen-dependent enzymes. | Elife | 2023 | 37494095 | PubTator, text mining | PubMed |
| The Fe-S cluster assembly protein IscU2 increases α-ketoglutarate catabolism and DNA 5mC to promote tumor growth. | Cell Discov | 2023 | 37488138 | PubTator, text mining | PubMed |
| Transcription factor expression repertoire basis for epigenetic and transcriptional subtypes of colorectal cancers. | Proc Natl Acad Sci U S A | 2023 | 37487069 | PubTator, text mining | PubMed |
| The role of m5C methyltransferases in cardiovascular diseases. | Front Cardiovasc Med | 2023 | 37476573 | PubTator, text mining | PubMed |
| Crosstalk between RNA m6A and DNA methylation regulates transposable element chromatin activation and cell fate in human pluripotent stem cells. | Nat Genet | 2023 | 37474847 | PubTator, text mining | PubMed |
| The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity. | Cancer Discov | 2023 | 37470668 | PubTator, text mining | PubMed |
| MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape. | J Biol Chem | 2023 | 37468105 | PubTator, text mining | PubMed |
| The impact and mechanism of TET3 overexpression on the progression of hepatic fibrosis. | Epigenomics | 2023 | 37464780 | PubTator, text mining | PubMed |
| MDM2 Antagonist Nutlin-3 Stimulates Global DNA Hydroxymethylation by Enhancing p53-TET1 Signaling Axis. | ACS Chem Biol | 2023 | 37463352 | PubTator, text mining | PubMed |
| Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development. | J Transl Med | 2023 | 37461108 | PubTator, text mining | PubMed |
| Tet2 regulates Sin3a recruitment at active enhancers in embryonic stem cells. | iScience | 2023 | 37456851 | PubTator, text mining | PubMed |
| TET1 facilitates specification of early human lineages including germ cells. | iScience | 2023 | 37456839 | PubTator, text mining | PubMed |
| Irradiation and lithium treatment alter the global DNA methylation pattern and gene expression underlying a shift from gliogenesis towards neurogenesis in human neural progenitors. | Transl Psychiatry | 2023 | 37443041 | PubTator, text mining | PubMed |
| The role of DNA methylation in human pancreatic neuroendocrine tumours. | Endocr Oncol | 2023 | 37434653 | PubTator, text mining | PubMed |
| In vivo CRISPR/Cas9 screening identifies Pbrm1 as a regulator of myeloid leukemia development in mice. | Blood Adv | 2023 | 37428871 | PubTator, text mining | PubMed |
| How molecular advances may improve the diagnosis and management of PTCL patients. | Front Oncol | 2023 | 37427095 | PubTator, text mining | PubMed |
| A novel m6A/m5C/m1A score signature to evaluate prognosis and its immunotherapy value in colon cancer patients. | J Cancer Res Clin Oncol | 2023 | 37421455 | PubTator, text mining | PubMed |
| Integrating machine learning algorithms to systematically assess reactive oxygen species levels to aid prognosis and novel treatments for triple -negative breast cancer patients. | Front Immunol | 2023 | 37404810 | PubTator, text mining | PubMed |
| Epigenetic mechanisms of Müller glial reprogramming mediating retinal regeneration. | Front Cell Dev Biol | 2023 | 37397254 | PubTator, text mining | PubMed |
| Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. | Exp Mol Med | 2023 | 37394582 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200424/papers?page=16